Method for treating uterine fibroids
AssigneesLaboratoire Hra-Pharma, The USA, as represented by the Secretary, Dept. of Health and Human Services
InventorsLynnette Nieman, Andre Ulmann, Diana Blithe, Erin Gainer
Life of this patent
Estimating the term…
Abstract
The invention relates to a method for treating uterine fibroids, which method comprises administering to a patient in need thereof, an effective amount of 17α-acetoxy-11β-[4-N,N-dimethylamino-phenyl) -19-norpregna-4,9-diene-3,20-dione (ulipristal) or any metabolite thereof. More particularly, the method is useful for reducing or stopping bleeding in a patient afflicted with uterine fibroids, and/or for reducing the size of uterine fibroids.
Claims17
A method for treating uterine fibroids or tumors derived therefrom, which method comprises administering to a patient in need thereof, an effective amount of 17α-acetoxy-11β-[4-N,N-dimethylamino-phenyl) -19-norpregna-4,9-diene-3,20-dione (ulipristal acetate) or any metabolite thereof.
A method for reducing or stopping bleeding in a patient afflicted with uterine fibroids, which method comprises administering to a patient in need thereof, an effective amount of 17α-acetoxy-11β-[4-N,N-dimethylamino-phenyl) -19-norpregna-4,9-diene-3,20-dione (ulipristal acetate) or any metabolite thereof.
A method for preventing or treating anemia in a patient afflicted with uterine fibroids, which method comprises administering to a patient in need thereof, an effective amount of 17α-acetoxy-11β-[4-N,N-dimethylamino-phenyl) -19-norpregna-4,9-diene-3,20-dione (ulipristal acetate) or any metabolite thereof.
A method for reducing the size of uterine fibroids, which method comprises administering to a patient in need thereof, an effective amount of 17α-acetoxy-11β-[4-N,N-dimethylamino-phenyl) -19-norpregna-4,9-diene-3,20-dione (ulipristal acetate) or any metabolite thereof.
A method for reducing uterine volume, which method comprises administering to a patient in need thereof, an effective amount of 17α-acetoxy-11β-[4-N,N-dimethylamino-phenyl) -19-norpregna-4,9-diene-3,20-dione (ulipristal acetate) or any metabolite thereof.
A method for preventing dissemination of uterine fibroids to other organs, in a patient afflicted with uterine fibroids, which method comprises administering to a patient in need thereof, an effective amount of 17α-acetoxy-11β-[4-N,N-dimethylamino-phenyl) -19-norpregna-4,9-diene-3,20-dione (ulipristal acetate) or any metabolite thereof.
A method for treating metastatic leiomyoma, which method comprising administering to a patient in need thereof, an effective amount of 17α-acetoxy-11β-[4-N,N-dimethylamino-phenyl) -19-norpregna-4,9-diene-3,20-dione (ulipristal acetate) or any metabolite thereof.
Dependencies are inferred from the claim text.